Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […]
Westfield Capital Management Co. LP decreased its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 19.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 785,494 shares of the biotechnology company’s stock after selling 188,989 shares during the quarter. Westfield Capital Management […]
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives $41.40 Consensus PT from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives Consensus Recommendation of "Hold" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Calamos Advisors LLC purchased a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 305,303 shares of the biotechnology company’s stock, valued at approximately $12,945,000. Calamos Advisors LLC owned 0.17% of Cerevel […]